This review outlines the distinctive features, classification, and diagnostic algorithms for pediatric pulmonary arterial hypertension, highlighting the reliance on adult studies for evidence.
These guidelines provide a comprehensive framework for the diagnosis and management of pediatric pulmonary hypertension in Saudi Arabia.
Pulmonary hypertension (PH) is relatively uncommon in children. Pulmonary arterial hypertension (PAH) in pediatric comprises a wide spectrum of diseases, from a transient neonatal condition to a progressive disease associated with morbidity and mortality. Most common PAH in pediatric are idiopathic (IPAH) or PAH associated with congenital heart disease (PAH-CHD), while other associated conditions, such as connective tissue disease (CTD), are less common in pediatrics. Despite better understanding of PH and the availability of new medications during recent decades; the diagnosis, investigation and choice of therapy remain a challenge in children, as evidence-based recommendations depend mainly on adult studies. In this review, we provide a detailed discussion about the distinctive features of PAH in pediatric, mainly emphacysing on classification and diagnostic algorithm.
Dabbagh et al. (Wed,) conducted a review in Pulmonary hypertension in children. Diagnosis and treatment guidelines was evaluated. This review outlines the distinctive features, classification, and diagnostic algorithms for pediatric pulmonary arterial hypertension, highlighting the reliance on adult studies for evidence.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: